Agoracom Blog Home

Posts Tagged ‘Cannabis’

Vertical $VERT.ca Announces Financing $TORR.ca $FA.ca $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM at 2:34 PM on Friday, January 24th, 2020

VANCOUVER, BC / January 24, 2020 / VERTICAL EXPLORATION INC. (TSXV:VERT) (“Vertical” or “the Company”) announces that it has arranged a non-brokered private placement of up to 26 million units (“Units”) at a price of $0.05 per Unit for aggregate gross proceeds of $1,300,000.00 (the “Offering”).

Each unit will be comprised of one common share (“Share”) and one-half of one transferable Share purchase warrant of the Company (“Warrant”). Each full Warrant will entitle the Subscriber to purchase one Warrant Share for a 24-month period after the Closing Date at an exercise price of $0.07 per share. Proceeds raised from the Offering will be used to advance the Company’s St. Onge project in Quebec, for general working capital and unallocated funds as per Tier 2 status requirements.

Finders’ fees may be payable on the private placement, subject to the policies of the TSX Venture Exchange.

This offering is subject to TSX Venture Exchange acceptance.

ABOUT VERTICAL EXPLORATION

Vertical Exploration’s mission is to identify, acquire, and advance high potential mining prospects located in North America for the benefit of its stakeholders. The Company’s flagship St-Onge Wollastonite property is located in the Lac-Saint-Jean area in the Province of Quebec.

ON BEHALF OF THE BOARD

Peter P. Swistak, President

FOR FURTHER INFORMATION PLEASE CONTACT: Telephone: 1-604-683-3995 Toll Free: 1-888-945-4770

NORTHBUD $NBUD.ca – Legalization 2.0 Product Rollout in Canada #Marijuana $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 12:59 PM on Monday, January 20th, 2020

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

Legalization 2.0 Product Rollout in Canada

  • The approval of these products is significant, both for consumers and for the cannabis industry in Canada
  • The infused products sector is large and very lucrative, and has already been hugely successful in parts of the US where cannabis is legal
  • It is also one with enormous growth potential. Some estimates suggest that the market will grow by a whopping $17 billion by 2022.

By Matt P

On October 17th, 2019, the Canadian government went ahead with the second phase of its cannabis program. Legalization 2.0 included the approval of edibles and infused products.  The move came exactly one year after the first wave of legalization which saw Canada make history, with recreational cannabis flower and oil hitting the legal market for the first time.

The approval of these products is significant, both for consumers and for the cannabis industry in Canada.  The infused products sector is large and very lucrative, and has already been hugely successful in parts of the US where cannabis is legal.  It is also one with enormous growth potential. Some estimates suggest that the market will grow by a whopping $17 billion by 2022.

While legalization occurred in October, Canadians still had not been able to purchase the new items. January 6th, 2020 marked the first day which vaporizers and cannabis-infused products were widely available to all Canadians.

Why Has It Taken So Long To Get Product Out?

Much of the delay has come from the restrictions imposed by the government.  All licensed producers looking to sell these new products are required to submit a 60 day notification directly to Health Canada. 

This means that the earliest date they would be available on shelves would be mid-December.  The timing was particularly important, since it fell right before the start of the holidays. Retailers and producers were looking to capitalize on making these hot new products readily available for holiday shoppers. 

Some retailers and consumers were lucky enough to get a limited supply before the holidays.  However, many had to wait until January 6th to finally get their hands on the new goodies.

Legalization 2.0 Product Rollout Across Canada

Whether or not you’ve had access to edibles before now depends largely on which part of Canada you’re living in. Consumers in British Columbia have had access to them since late December. Residents were able to purchase both through BC’s online store as well as through a number of private dispensaries. Edibles hit the shelves just in time for the holidays.  Saskatchewan was another province that saw edibles become available just before December 25th.

For other parts of the country, January 6th was the first time residents could pick up the new products.  In Ontario, Alberta and Quebec, the rollout for legalization 2.0 was delayed until January.  This was mainly due to the fact that all three provinces maintain their own distribution system, as opposed to allowing licensed producers to interact directly with retailers.

Image Courtesy of Alexander Stein

In Alberta, January 6th marked the first day that stores were able to place their orders with the AGLC, which acts as the cannabis wholesaler for the provinces retailers.  There are currently a limited number of products available, but that’s expected to change.  AGLC spokeswoman Heather Holman commented on the situation, saying that “right now in Alberta, AGLC has contracts with 43 federally licensed producers.  They manufacture a variety of products. About half of those licensed producers will be providing for what we’re calling cannabis 2.0 (which are) the new line of products like edibles, extracts and topicals. What we see this week and the coming weeks isn’t reflective of the bigger picture.”

In Ontario, online sales through the Ontario Cannabis Store began at 9:00am Thursday, January 16th. The store subsequently sold out of all product by 2:00pm on the same day.  The online retailer announced last week that they’d be carrying 59 new cannabis products.

Quebec and Legalization 2.0

The situation is significantly more complicated in the province of Quebec.  The province has the distinction of having the strictest cannabis laws in the country. The province also passed a law raising the age of consumption to 21 back in October.

Although they officially rolled out the new products this month, these strict laws extend to legalization 2.0.  In addition to heavy-handed age of consumption laws, the province has also passed a number of restrictions on these new products.  Infused products such as chocolates and baked goods have been banned.  So have vape pens and cartridges. Quebec officials enacted the bans based on fears that the products could appeal to minors.

For the time being, it seems that users in Quebec will have to make do with a much more limited selection than the rest of the country.

Issues And Potential Hurdles

Much like the original rollout of legal cannabis flower in 2018, things haven’t gone as smoothly as both the government and cannabis industry would have liked.  Along with the delays in multiple provinces, there have also been other issues.

The Aphria Recall

In a case of terrible timing, cannabis giant Aphria was forced to recall its line of vape pens. The recall was due to leaky vape cartridges.  According to chief corporate affairs officer Tamara Macgregor, “out of an abundance of caution we asked provincial customers to return certain initially shipped ‘510 cartridges’ that did not meet our intended consumer experience.”

Like most of the licensed producers in Canada, Aprhia has no doubt had their eyes set on this second wave of legalization (particularly given what a disappointing year 2019 was).

Vaping Restrictions

One of the big issues plaguing the cannabis industry over the past year has been the backlash against vaping across the country.  Effective as of January 1st, Ontario has implemented an advertising ban on all vape products in convenience stores and gas stations.  The move was prompted from data indicating that more young people are vaping, and is designed to bring the current laws in line with provincial tobacco laws.

Image Courtesy of Lexphumirat

The move didn’t effect the cannabis industry directly. The Ontario cannabis Store and licensed retailers are responsible for the sale of cannabis vapes. However, the fact that provincial lawmakers are willing to target vaping more broadly is troubling.  Along with Quebec, Newfoundland and Labrador have also banned cannabis vapes. Officials in British Columbia plan to raise taxes on these products specifically to 20%.

These moves have no doubt left the industry very concerned. Canada will continue to be a proving ground for legalization as Cannabis 2.0 rollout continues.

Source: https://www.puffpuffpost.com/legalization-2-0-rollout-canada-success-and-failure/

NORTHBUD $NBUD.ca – High demand: Ontario’s online #Cannabis 2.0 products sell out fast $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 2:56 PM on Thursday, January 16th, 2020

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

High demand: Ontario’s online Cannabis 2.0 products sell out fast

By David George-Cosh

More than 2,000 people placed orders within the first hour that cannabis-infused edibles and vape products became available for sale on the Ontario Cannabis Store’s website, a spokesperson told BNN Bloomberg.

Beginning Thursday at 9 a.m. ET, the website listed 50 vape products and 21 pot-infused gummies for sale, a slight increase from the number of items available at Ontario’s brick-and-mortar cannabis retailers.

More than 3,000 people were waiting in a “digital queue” before the online sales began. Due to the high demand, the website experienced several crashes for some products, while all “soft-chew” items, or gummies, were sold out within the first 30 minutes.

OCS spokesperson Daffyd Roderick told BNN Bloomberg the government agency is managing the website’s traffic issues and plans to replenish any sold-out items after bricks-and-mortar stores have been allotted an equal share of available product.

“We know the licensed producers are working hard to make more products available and we’re confident that these growing pains will be moved through in relatively short order,” Roderick said.

While some of the next-generation cannabis products on the website have been available at physical Ontario cannabis stores since earlier this month, the various cannabis-infused cookies, soft chews, mints, tea and vapes for sale represent a potential new windfall for the country’s pot producers, who have been stymied over the past year with softer-than-expected revenue from dried flower products.

Raymond James analysts said in a recent report that cannabis producers should report material revenue from the latest rollout of Cannabis 2.0 products in the second-half of this year.

Cannabis Canada is BNN Bloomberg’s in-depth series exploring the stunning formation of the entirely new — and controversial — Canadian recreational marijuana industry. Read more from the special series here and subscribe to our Cannabis Canada newsletter to have the latest marijuana news delivered directly to your inbox every day.

Source: https://www.bnnbloomberg.ca/high-demand-ontario-s-online-cannabis-2-0-products-sell-out-fast-1.1375048

Spyder #Cannabis $SPDR.ca – DOPE! New cannabis compound 30 TIMES more potent than #THC found in one #marijuana variety $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 1:00 PM on Monday, January 13th, 2020

SPONSOR: Spyder Cannabis (SPDR:TSXV) An established chain of high-end vape stores. Aggressive expansion plan is already in place that will focus on Canadian retail and US Hemp derived kiosks in high traffic areas. Click here for more info.

DOPE! New cannabis compound 30 TIMES more potent than THC found in one marijuana variety

  • Compound is one of two newfound cannabinoids that have been discovered in the Cannabis plant glands of the sativa L species.

By: Charlotte Edwards

A NEW cannabis compound has been discovered and it may be 30 times more potent than THC.

Scientists aren’t yet sure whether the compound causes a high or has medical benefits so they’ve been conducting tests to try and figure this out.

The compound is one of two newfound cannabinoids that have been discovered in the Cannabis plant glands of the sativa L species.

Cannabinoids is the collective term for the group of diverse chemical compounds that act on the cannabinoid receptors of the brain.

THC is just one of these cannabinoids and it’s currently considered to be the principal psychoactive component of cannabis.

THC, or tetrahydrocannabinol, plugs into brain receptors and can alter our ability to co-ordinate movements, reason, record memories and perceive things like time and pleasure.

  THC in cannabis is what can give smokers a high feelingCredit: Getty – Contributor

It’s thought that cannabis contains over 140 similar chemicals that can interact with receptors all over the body.

However, THC is currently the only one we know can result in a high spaced out feeling.

Of the two new cannabinoids discovered, one looks similar to the compound CBD, which isn’t psychoactive.

The other appears similar to THC but may even produce stronger mind-bending effects.

This THC lookalike is called tetrahydrocannabiphorol (THCP).

Recent research suggests that it interacts with the same brain receptor as THC but has slight differences in its chain of atoms.

The slight difference in shape of THCP means it can technically fit more snugly into its preferred brain receptor than THC.

A test showed that the compound can actually bind 30 times more reliably than THC.

When given to lab mice, the THCP made them behave as if they were on THC with slower movements and decreased reactions to pain.

The mice reached this state with a much lower does than would have been required with THC meaning the new compound is stronger.

However, this lab experiment still doesn’t mean that the same effect would happen in humans.

THCP doesn’t appear to be present in large amounts in cannabis plants but even if it was, increased psychoactive properties would still not be guaranteed.

Source: https://www.thesun.co.uk/tech/10725348/new-cannabis-compound-more-potent-weed/

CLIENT FEATURE: Vertical Exploration $VERT.ca Partners with AREV Brands to Distribute Wollastonite to the Cannabis and Hemp Industries $TORR.ca $FA.ca $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM at 7:38 PM on Friday, January 10th, 2020
http://blog.agoracom.com/wp-content/uploads/2019/11/VERT-square-logo.png
  • Definitive distribution agreement to partner on the sale of Vertical’s wollastonite from its world-class St-Onge Deposit in place.
  • Supplying the fast growing cannabis and hemp industries.
  • Vertical’s high quality Wollastonite has been shown to be beneficial to cannabis plants in a variety of ways
  • In every case the most optimal results occurred with an admixture rate of 10% to 15% wollastonite to the growth medium.
  • The high-grade St-Onge Wollastonite deposit has pit-constrained mineral resources of: 7,155,000 tonnes Measured@ 36.20% Wollastonite & 6,926,000 tonnes Indicated@ 37.04%
  • B.C. Buds Testing Confirmed Wollastonite is critical to marijuana growers
  • Engaged AGRINOVA over the past year to conduct research and testing of Vertical’s St-Onge wollastonite on a range of important agricultural end uses.

WOLLASTONITE

  • St-Onge-Wollastonite Deposit located approximately 90 kilometres Northwest of the city of Saguenay, in St-Onge township, in the Saguenay-Lac-St-Jean region of Quebec, Canada.
  • Wollastonite is a calcium inosilicate mineral that may contain small amounts of ironmagnesium, and manganese substituting for calcium
  • Research and testing in the Phase 1 program for use in cannabis growth was managed and monitored by AGRINOVA, a highly-regarded Center for Research and Innovation in Agriculture in Quebec

St-Onge-Wollastonite Deposit:

VERT Hub on Agoracom

FULL DISCLOSURE: Vertical Exploration is an advertising client of AGORA Internet Relations Corp.

Spyder #Cannabis $SPDR.ca – Exploring Canada’s Cannabis Demand-Supply Landscape $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 4:48 PM on Thursday, January 9th, 2020

SPONSOR: Spyder Cannabis (SPDR:TSXV) An established chain of high-end vape stores. Aggressive expansion plan is already in place that will focus on Canadian retail and US Hemp derived kiosks in high traffic areas. Click here for more info.

Exploring Canada’s Cannabis Demand-Supply Landscape

By Sushree Mohanty

  • Cannabis demand is rising
  • However, there seems to be a gap between cannabis demand and supply in Canada
  • It’s been a year since Canada legalized marijuana, but it seems consumers in the country are still struggling to obtain legal cannabis
  • This demand-supply imbalance took a toll on cannabis companies’ revenues and stock prices last year

Let’s take a closer look at the demand-supply imbalance in Canada.

The cannabis demand-supply landscape in Canada

Health Canada has come up with a national Cannabis Tracking System to keep track of the cannabis produced and sold across the country. The intention is to keep a check on illegal cannabis sales. Health Canada requires federal license holders and provincial and territorial growers to report this data on a monthly basis.

Another objective behind this move could be to ensure that cannabis producers aren’t growing marijuana illegally. Such was the case last year with CannTrust (NYSE:CTST). The company was found to be growing marijuana illegally and was reportedly in violation of Health Canada’s regulations.

The monthly report tracks the sales of medical and recreational marijuana. It also takes into account the cannabis inventories held by retailers and distributors. Here are a few details from the report for the period that ended on September 30, 2019:

  • Total sales of dried cannabis fell by 0.4% to 12,922 kilograms on a month-to-month basis.
  • Cannabis oil total sales rose by 4.8% to 11,187 liters on a month-to-month basis.
  • The total amount of finished dried cannabis inventory rose by 5% to 64,151 kilograms on a month-to-month basis.
  • The total amount of finished cannabis oil inventory rose by 1.1% to 102,060 liters on a month-to-month basis.

“Finished inventory” here implies that the products are ready and packed for sale. The finished inventory for dried cannabis was higher for both provincial and territorial distributors and retailers and federal license holders.

For dried cannabis, federal license holders saw a 5.7% increase in finished inventories, while provincial and territorial distributors and retailers saw a 4.3% increase. Additionally, for cannabis oil, federal license holders saw a 2.6% increase in inventories, while provincial and territorial distributors and retailers saw a 1.4% decrease.

What caused the imbalance?

Canada legalized marijuana in October 2018. The demand for marijuana was high in the country. Thus, producers cultivated more cannabis, hoping to meet this demand. However, regulatory procedures were slow and strenuous, which resulted in a delay in the licensing and opening of new legal stores. The delay resulted in higher inventories and caused supply issues. Hence, cannabis sales were affected across Canada. Looking at the data for September, we can conclude that most retailers had products ready for sale. However, the lack of stores caused a supply issue and a rise in inventory.

Moreover, the licensing process isn’t that simple. A Cannabiz Media article stated, “The amount of time to obtain a license to grow marijuana in Canada’s legal market was excessive with some cultivators waiting months or even a year. Once a grower obtained a cultivation license, it needed to produce two full crops, have them tested, get its sales software audited, and apply for a sales license, which could take another year.”

How’s the marijuana demand and supply situation in the US?

While we’re on the subject, let’s talk about the demand and supply situation in the US. Marijuana isn’t legal at the federal level in the US. However, 33 states and the District of Columbia allow medical marijuana. Additionally, 11 states and the District of Columbia allow recreational marijuana.

Black market sales are a matter of concern even in the US. California, which legalized medical marijuana in 1996 and adult-use marijuana in 2016, also suffers from illicit cannabis activity. An article by Cannabis Business Plan discussed how cannabis consumers in the state will initially be inclined toward the illegal market to avoid regulatory costs. The article also stated that predictions show that by 2022, the marijuana market in the state could be worth $7.7 billion driven mostly by recreational marijuana.

Cannabiz Media also discussed how states such as Michigan are facing supply shortages due to a lack of licensed growers. Recently, recreational marijuana sales went live in Michigan. Pennsylvania faced similar problems when demand for medical cannabis couldn’t match supply in the state.

Furthermore, the abundance of marijuana resulted in losses for many licensed cultivators as prices fell. Obtaining capital for cannabis businesses is still an issue in the US. Banks and financial institutions are scared to provide help to cannabis companies because marijuana is still illegal federally. However, hopes are that the passing of the SAFE Act could smooth this process.

How are cannabis companies coping with the demand-supply situation?

The demand-supply imbalance hit cannabis companies’ revenues and profitabilities last year. After Canada legalized cannabis, companies increased their production capacities to match demand. However, the lack of legal stores caused a supply issue. Initially, Ontario was strict with its cannabis laws. Recently, though, after the second phase of legalization, Ontario relaxed its laws to tackle the problem of black market sales. Canada’s three largest provinces now expect higher sales this year from the Cannabis 2.0 expansion.

Hence, Aurora Cannabis (NYSE:ACB), Canopy Growth (TSE:WEED), Cronos Group (NASDAQ:CRON), and HEXO (TSE:HEXO) have struggled with overproduction. The companies missed their revenue targets and reported lower profitabilities in 2019. HEXO even withdrew its fiscal 2020 outlook due to lower store rollout issues.

Cannabis edibles are in high demand among marijuana products. Hence, consumers turned to the black market to obtain these products when Canada hadn’t legalized edibles. The prices of cannabis products on the black market are also lower than they are on the legal market. Now, with Cannabis 2.0 products ready to hit the stores, marijuana companies expect to recover their losses in 2020. These companies are ready with a variety of edibles, vapes, and beverages.

Though analysts expect a turnaround in 2020, they’ve kept a subdued outlook on marijuana companies’ 2020 revenues. Some analysts feel regulations and licensing delays could still affect Cannabis 2.0 revenues this year. Companies’ 2020 revenue estimates are as follows:

  • Aurora Cannabis’s fiscal 2020 revenue could be around 371.6 million Canadian dollars.
  • Canopy Growth’s (NYSE:CGC) fiscal 2020 revenue could be around 403.3 million Canadian dollars.
  • Cronos Group’s fiscal 2020 revenue could be around 146.1 million Canadian dollars.
  • HEXO’s fiscal 2020 revenue could be around 79.1 million Canadian dollars.

Final thoughts

The demand-supply imbalance in the cannabis market is an important issue. However, we also have to consider that the industry is a growing one and will have its ups and downs. Currently, the flow of regulations isn’t smooth, which is causing licensing and cultivation delays. It may take some time for things to smooth out in the industry.

Many also feel that federal legalization will help balance the demand-supply issue in the US. Nevertheless, considering the efforts by Canada and certain states in the US, we can expect a turnaround in 2020.

Stay tuned to learn more about the ins and outs of the marijuana industry.

Source: https://articles2.marketrealist.com/2020/01/exploring-canadas-cannabis-demand-supply-landscape/#

North Bud Farms $NBUD.ca Provides Corporate Update $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 4:16 PM on Thursday, January 9th, 2020
  • In late December completed first harvest at Salinas, California cultivation facility
  • Harvested 2,687 plants that were included in the acquisition of the Qlora Group

TORONTO, Jan. 09, 2020 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company“) is pleased to provide shareholders with the following corporate update:

Cannabis Production Facility in Salinas, California

In late December we completed our first harvest at our Salinas, California cultivation facility. We harvested 2,687 plants that were included in the acquisition of the Qlora Group (“Qlora”). The Company anticipates completing testing and sale of the product in late January 2020, which will represent the first revenue generated by the Company in California.  The Company has also completed an in-depth review and analysis of both the infrastructure and cultivation practices and will be implementing significant efficiencies over the course of the next four harvests. The Company anticipates continual harvests of 2,000-3,000 plants every 25 days, with quality and yield improving with each harvest. This product will be sold via wholesale agreements to existing Qlora clients in the interim as we prepare for the launch of NORTHBUD branded flower products in California in the third quarter of 2020.  

“Despite challenges faced by the cultivation team during this period of transition, we are extremely excited to be harvesting our first crops and look forward to continual improvements as we implement procedural and infrastructure efficiencies,” said Justin Braune, President of Bonfire Brands USA, a wholly owned subsidiary of NORTHBUD.

Cannabis Production Facility in Reno, Nevada

The Company is pleased to announce the completion of the first harvest of approximately 175 indoor grown plants. Upon the completion of testing and processing, the product will be distributed as NORTHBUD flower, pre-rolls and infused pre-rolls into selected Nevada dispensaries. The launching of NORTHBUD branded products into Nevada marks a significant milestone for the Company.

Status of Cultivation Licence Application for Cannabis Production Facility in Low, Quebec

On September 18, 2019, the Company received a confirmation of receipt of the site evidence package submitted in late August 2019. On November 22, 2019, the Company received a request for information from Health Canada (the “Request”).  The Request was received within the 60-business day service window for feedback provided by the regulator.  The Company is pleased to report that the Request was responded to in full in advance of the December 8th deadline. The Request did not contain any notices of deficiencies in the Company’s cultivation licence application nor did it require the Company to make any modifications or changes to its facility.

On December 19, 2019 the Company received a subsequent follow-up request for information consisting of two questions which were responded to that same day, and on December 20th, the Company received a request to clarify the roles of recently-hired employees in relation to the requested cultivation licence. This request was responded to in full on January 3, 2020. The Company has received no further communication from Health Canada.

The Company is confident that the approval process is on track and within comparable timelines experienced by other publicly-traded companies who have recently submitted evidence packages.  At this time, the Company cannot predict when it will be granted a cultivation licence by Health Canada. The Company will update shareholders on any further progress on the application.

Annual General Meeting

The Company wishes to inform shareholders that it will hold its Annual General and Special Meeting at 1:00 p.m. ET on Monday, February 3, 2020 at the office of McMillan LLP, World Exchange Plaza, Suite 2000, Ottawa, Ontario. The Company will file the required information for the annual and special meeting under its issuer profile on SEDAR at www.sedar.com.

Staffing and Personnel

The Company is pleased to announce the hiring of Adam Shapero as General Counsel. Adam comes to NORTHBUD after serving as Director of Risk Management, Corporate Secretary and Senior Counsel at Origin House (CSE: OH), who was recently acquired by Cresco Labs (CSE: CL) in a transaction valued at ~ $520 million. “We are extremely pleased to welcome Adam to our team,” said Sean Homuth, CEO of NORTHBUD. “His first-hand experience in the Cannabis industry will add tremendous value to our team while reducing our reliance on external counsel.”

About North Bud Farms Inc.

North Bud Farms Inc., through its wholly owned subsidiary GrowPros MMP Inc., is pursuing a license under The Cannabis Act.  The Company has built a state-of-the-art purpose-built cannabis production facility located on 135 acres of Agricultural Land in Low, Quebec, Canada. NORTHBUD through its wholly owned U.S. subsidiary, Bonfire Brands USA has acquired cannabis production facilities in California and Nevada. The Salinas, California property is located on 11 acres which currently consists of a 300,000 sq. ft. of licensable greenhouse space with 60,000 sq. ft. actively cultivating cannabis and a 2,000 sq. ft. building licensed for distribution.  The Reno, Nevada property is located on 3.2 acres of land which was acquired through the acquisition of Nevada Botanical Science, Inc. a world class cannabis production, research and development facility with 5,000 sq. ft. of indoor cultivation which holds medical and adult use licenses for cultivation, extraction and distribution.

For more information visit: www.northbud.com

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements and information included in this press release that, to the extent they are not historical fact, constitute forward-looking information or statements (collectively, “forward-looking statements”) within the meaning of applicable securities legislation.  Forward-looking statements, including, but not limited to, those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management.

Forward-looking statements, including, but not limited to, those regarding the success of the Company’s licence application in Quebec, future sales of cannabis in California and Nevada, plant harvest yields at the Company’s California and Nevada operations, conditions in the cannabis market, the Company entering agreements in connection with the B2B supply of cannabis and the Company’s transition into a revenue generating operational phase of development are based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements.  Such risks and uncertainties include, among others, the risk factors included in the Company’s final long form prospectus dated August 21, 2018, which is available under the Company’s SEDAR profile at www.sedar.com. Accordingly, readers should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statements to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]

NORTHBUD $NBUD.ca – When #CBD met chocolate $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 11:00 AM on Thursday, January 9th, 2020

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

When CBD met chocolate

The health-conscious, environmentally-aware consumer has encouraged new trends in the chocolate sector that affect flavour, texture and harvesting. Greater Goods has gone one step further, infusing the beloved food of the gods with CBD. Bethan Grylls hears from its co-founder about why this combination works.

Indulgent, premium and good-for-you: these words will be familiar to the modern-day confectioner as they look to address current trends1 and differentiate themselves in a competitive market. Be it a new sensory experience across taste, texture or colour; the lure of single-origin sourcing; or a guilt-free treat, the realms of chocolate innovation and buyer demands have stretched well beyond the days of penny sweets.

Some brands have taken things one step further, combining trends like organic, fair trade and non-GMO confectionery, with the demand for CBD – a term that was Googled 6. 4 million times during April 2019.2

Greater Goods, based in Oregon, US, is one example, offering its customers a selection of cannabinoid-infused ‘goodies’. Despite being a modest husband and wife venture, the team says they are looking to compete against the larger companies through hand-crafted, fun and unusually-flavoured products.

Source: https://www.newfoodmagazine.com/article/101342/when-cbd-met-chocolate/

NORTHBUD $NBUD.ca – Canadians Bought 100 Tonnes Of Legal #Cannabis In First Year $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 10:45 AM on Wednesday, January 8th, 2020

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

Canadians Bought 100 Tonnes Of Legal Cannabis In First Year

  • Canadians bought nearly 100 tonnes of legal recreational cannabis in its first year of availability, according to new figures released by Health Canada.

Health Canada said 88,676 kilograms of dried flower cannabis was sold in Canada in the first year of legalization, according to its Cannabis Tracking System. Overall sales of legal dried cannabis by weight have nearly tripled since October 2018.

Statistics Canada said Tuesday that Canadian household spending on cannabis totaled $1.27 billion in the third quarter of 2019, with the illicit market accounting for $860 million of that figure and the legal market estimated at $417 million.

While 100 tonnes may sound like a lot, the amount sold through legal channels was far below what analysts projected Canadian demand would be, a sign that the illicit market continues to weigh on legal sales. CIBC World Markets said in mid-2018 that the Canadian market would demand about 400,000 kilograms of legal pot annually, while the Bank of Nova Scotia forecast total cannabis demand in Canada will be 900,000 kilograms this year.

Health Canada also said that the total active cultivation area for cannabis in the country reached 1.78 million square metres at the end of September, a sizable jump from the 452,896 square meters of cultivation that was licensed for legal pot a year earlier. Nearly five million cannabis plants were being grown by producers at the end of the first year of legalization, Health Canada said.

Source: https://menafn.com/1099515194/Canadians-Bought-100-Tonnes-Of-Legal-Cannabis-In-First-Year

Spyder #Cannabis $SPDR.ca – More Canadians passing on beer in year one of legalization $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 5:00 PM on Tuesday, January 7th, 2020

SPONSOR: Spyder Cannabis (SPDR:TSXV) An established chain of high-end vape stores. Aggressive expansion plan is already in place that will focus on Canadian retail and US Hemp derived kiosks in high traffic areas. Click here for more info.

More Canadians passing on beer in year one of legalization

The report cites data from industry advocacy group Beer Canada, which found beer volumes fell by three per cent through November. Declining sales have led to several partnerships between alcohol and cannabis companies, such as Constellation Brands Inc.’s investment in Canopy Growth Corp. in November 2018. The recent decline in volumes is “far worse” than trends seen in the previous four years, when beer industry volumes fell an average of 0.3 per cent, according to Cowen & Co. analyst Vivien Azer.

Source: http://links.mkt2011.com/servlet/MailView?ms=MzA4MjU2MzMS1&r=MjU5OTkyNTIyMjg1S0&j=MTYyMzQzMjQyOAS2&mt=1&rt=0